| Literature DB >> 23671628 |
Woo Hyun Lee1, Jee Hye Wee, Dong-Kyu Kim, Chae-Seo Rhee, Chul Hee Lee, Soyeon Ahn, Ju Hyun Lee, Yang-Sun Cho, Kun Hee Lee, Kyung Soo Kim, Si Whan Kim, Ari Lee, Jeong-Whun Kim.
Abstract
BACKGROUND: Population-based studies for olfactory dysfunction are lacking. The aim of this study is to evaluate the prevalence of subjective olfactory dysfunction and its risk factors in the Korean general population.Entities:
Mesh:
Year: 2013 PMID: 23671628 PMCID: PMC3650050 DOI: 10.1371/journal.pone.0062725
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Prevalence of olfactory dysfunction according to the general characteristics of KNHNES participants according to the presence of olfactory dysfunction (weighted for the multistage sampling design of KNHANES 2009).
| Olfactory dysfunction Weighted, % (SE) | ||||
| Characteristics | Unweighted total number | No | Yes | P value |
|
| 7306 | 95.5 (0.4) | 4.5 (0.4) | |
|
| <0.001 | |||
| 20–29 | 936 | 97.4 (0.5) | 2.6 (0.5) | |
| 30–39 | 1407 | 96.5 (0.6) | 3.5 (0.6) | |
| 40–49 | 1473 | 96.7 (0.6) | 3.3 (0.6) | |
| 50–59 | 1233 | 94.7 (0.8) | 5.3 (0.8) | |
| 60–69 | 1203 | 92.6 (1.0) | 7.4 (1.0) | |
| ≥70 | 1054 | 91.4 (1.0) | 8.6 (1.0) | |
|
| 0.302 | |||
| Male | 3149 | 95.3 (0.5) | 4.7 (0.5) | |
| Female | 4157 | 95.8 (0.4) | 4.2 (0.4) | |
|
| <0.001 | |||
| ≤Middle school | 2867 | 93.7 (0.7) | 6.3 (0.7) | |
| ≥High school | 4380 | 96.3 (0.4) | 3.7 (0.4) | |
| Missing | 59 | |||
|
| <0.001 | |||
| ≤50 percent | 3240 | 94.2 (0.6) | 5.8 (0.6) | |
| >50 percent | 3983 | 96.4 (0.4) | 3.6 (0.4) | |
| Missing | 83 | |||
|
| 0.022 | |||
| White collar | 5287 | 95.9 (0.4) | 4.1 (0.4) | |
| Blue collar | 1937 | 94.5 (0.6) | 5.5 (0.6) | |
| Missing | 82 | |||
|
| 0.469 | |||
| Rural | 5408 | 95.4 (0.5) | 4.6 (0.5) | |
| Urban | 1898 | 96.0 (0.6) | 4.0 (0.6) | |
|
| 0.601 | |||
| <25 kg/m2 | 4926 | 95.4 (0.5) | 4.6 (0.5) | |
| ≥25 kg/m2 | 2331 | 95.7 (0.5) | 4.3(0.5) | |
|
| 0.001 | |||
| Exposure | 399 | 92.0 (1.6) | 8.0 (1.6) | |
| No exposure | 6884 | 95.7 (0.4) | 4.3 (0.4) | |
| Missing | 23 | |||
|
| 0.399 | |||
| Exposure | 230 | 94.2 (1.9) | 5.8 (1.9) | |
| No exposure | 7053 | 95.6 (0.4) | 4.4 (0.4) | |
| Missing | 23 | |||
|
| 0.709 | |||
| <5 packs | 4382 | 95.6 (0.4) | 4.4 (0.4) | |
| ≥5packs | 2864 | 95.4 (0.5) | 4.6 (0.5) | |
| Missing | 60 | |||
|
| 0.519 | |||
| ≤4times/month | 5746 | 95.6 (0.4) | 4.4 (0.4) | |
| ≥2times/week | 1573 | 95.2 (0.7) | 4.8 (0.7) | |
| Missing | 23 | |||
SE, standard error; Air pollutants, habitual exposure to air pollutants in workplace; Chemical substance, habitual exposure to chemical substances in workplace.
Figure 1Prevalence of subjective olfactory dysfunction by age groups and genders.
There were increasing tendency of olfactory dysfunction prevalence with increasing age in both genders, asterisk; p<0.05.
Prevalence of olfactory dysfunction according to the medical conditions of KNHANES participants.
| Olfactory dysfunction Weighted, % (SE) | ||||
| Characteristic | Unweighted total number | No | Yes | P value |
|
| ||||
| Chronic rhinosinusitis | 402 | 68.8 (3.3) | 31.2 (3.3) | <0.001 |
| Rhinitis | 1696 | 91.6 (0.9) | 8.4 (0.9) | <0.001 |
| Chronic otitis media | 261 | 90.5 (2.4) | 9.5 (2.4) | 0.001 |
| Septal deviation | 3090 | 95.2 (0.5) | 4.8 (0.5) | 0.405 |
|
| ||||
| Hypertension | 1513 | 93.8 (0.7) | 6.2 (0.7) | 0.001 |
| Stroke | 143 | 93.7 (1.8) | 6.3 (1.8) | 0.236 |
| Angina | 137 | 94.1 (2.0) | 5.9 (2.0) | 0.398 |
| Arrhythmia | 292 | 95.5 (1.1) | 4.5 (1.1) | 0.963 |
|
| ||||
| Diabetes mellitus | 573 | 95.7 (0.8) | 4.3 (0.8) | 0.850 |
| Thyroid disease | 254 | 89.9 (2.7) | 10.1 (2.7) | 0.001 |
| Hyperlipidemia | 574 | 94.4 (1.1) | 5.6 (1.1) | 0.205 |
| Low-HDL cholesterolemia | 1802 | 94.0 (0.9) | 6.0 (0.9) | 0.014 |
|
| ||||
| Tuberculosis | 400 | 95.5 (0.4) | 4.5 (0.4) | 0.833 |
| Asthma | 224 | 87.9 (3.7) | 12.1 (3.7) | 0.001 |
| COPD | 43 | 94.7 (2.7) | 5.3 (2.7) | 0.749 |
| Bronchiectasis | 25 | 90.0 (7.5) | 10.0 (7.5) | 0.296 |
|
| ||||
| Gastric ulcer | 452 | 95.3 (1.1) | 4.7 (1.1) | 0.800 |
| Hepatitis B | 86 | 86.4 (4.6) | 13.6 (4.6) | 0.001 |
|
| ||||
| Rheumatoid arthritis | 148 | 93.6 (2.3) | 6.4 (2.3) | 0.336 |
| Arthritis | 967 | 92.4 (1.1) | 7.6 (1.1) | <0.001 |
| Osteoporosis | 539 | 90.6 (1.5) | 9.4 (1.5) | <0.001 |
|
| ||||
| Gastric cancer | 49 | 86.3 (6.2) | 13.7 (6.2) | 0.016 |
| Hepatic cancer | 11 | 94.7 (10) | 5.3 (5.3) | 0.870 |
| Colon cancer | 17 | 89.4 (8.3) | 10.6 (8.3) | 0.260 |
|
| ||||
| Depression | 277 | 93.8 (1.6) | 6.2 (1.6) | 0.195 |
| Anemia | 473 | 95.2 (1.0) | 4.8 (1.0) | 0.751 |
| Atopic dermatitis | 161 | 93.0 (2.1) | 7.0 (2.1) | 0.121 |
| Cataract | 660 | 92.5 (1.1) | 7.5 (1.1) | <0.001 |
HDL, high density lipoprotein; COPD, chronic obstructive pulmonary disease;
All ENT diseases were diagnosed by ENT residents.
Comparison of blood/urine tests between normosmic and hyposmic participants.
| Olfactory dysfunction weighted (SE) | |||
| Variable | No | Yes | P value |
|
| |||
| Fasting glucose (mg/dL) | 96.90 (1.30) | 97.39 (1.24) | 0.705 |
| HbA1C (%) | 7.30 (0.23) | 7.37 (0.21) | 0.761 |
| Insulin (µIU/mL) | 9.89 (0.32) | 9.56 (0.31) | 0.300 |
| Total cholesterol (mg/dL) | 186.14 (2.20) | 186.60 (2.17) | 0.835 |
| HDL cholesterol (mg/dL) | 52.28 (0.88) | 50.03 (0.88) | 0.010 |
| Triglyceride (mg/dL) | 135.70 (7.80) | 143.98 (7.76) | 0.289 |
| LDL cholesterol (mg/dL) | 110.96 (4.79) | 106.35 (4.71) | 0.337 |
| GOT (IU/L) | 22.41 (0.88) | 24.35 (0.85) | 0.037 |
| GPT (IU/L) | 22.49 (1.73) | 23.80 (1.71) | 0.451 |
| BUN (mg/dL) | 14.17 (0.25) | 14.81 (0.25) | 0.013 |
| Vitamin D (ng/mL) | 17.74 (0.40) | 17.76 (0.43) | 0.953 |
| Alkaline phosphatase (IU/L) | 221.99 (3.43) | 222.19 (3.32) | 0.954 |
| Lead (µg/dL) | 2.49 (0.14) | 2.89 (0.14) | 0.006 |
| Mercury (µg/L) | 5.10 (0.41) | 5.80 (0.41) | 0.094 |
| Cadmium (µg/L) | 1.08 (0.07) | 1.09 (0.07) | 0.936 |
|
| |||
| Creatinine (mg/L) | 158.54 (6.03) | 143.99 (5.86) | 0.017 |
| Sodium (g/day) | 131.69 (4.00) | 134.51 (3.94) | 0.482 |
| Cotinine (ng/mL) | 445.86 (64.07) | 393.55 (63.01) | 0.415 |
HbA1c, hemoglobin A1c; HDL, high density lipoprotein; LDL, low density lipoprotein; GOT, glutamic oxaloacetic transaminase; GPT, glutamic pyruvic transaminase; BUN, blood urea nitrogen.
Adjusted odds ratio for the association between olfactory dysfunction and risk factors.
| Exposure | Adjusted OR | CI | P value |
| Age group | |||
| 20–29 | 1.00 | ||
| 30–39 | 1.08 | 0.60–1.95 | 0.792 |
| 40–49 | 1.31 | 0.73–2.37 | 0.360 |
| 50–59 | 2.09 | 1.16–3.77 | 0.014 |
| 60–69 | 2.58 | 1.31–5.08 | 0.006 |
| ≥70 | 3.71 | 1.93–7.14 | <0.001 |
| Income (≤50 percent) | 1.43 | 1.01–2.03 | 0.042 |
| Education (≤Middle school) | 0.67 | 0.43–1.04 | 0.075 |
| Occupation (Blue collar) | 1.21 | 0.86–1.69 | 0.256 |
| Air pollutants | 2.18 | 1.33–3.55 | 0.002 |
| Hypertension | 0.94 | 0.63–1.41 | 0.796 |
| Arthritis | 0.99 | 0.62–1.58 | 0.968 |
| Osteoporosis | 1.32 | 0.81–2.13 | 0.259 |
| Asthma | 1.84 | 0.81–4.20 | 0.143 |
| Depression | 0.85 | 0.38–1.87 | 0.688 |
| Atopic dermatitis | 1.16 | 0.50–2.69 | 0.713 |
| Thyroid disease | 1.71 | 0.83–3.50 | 0.142 |
| Cataract | 1.06 | 0.69–1.63 | 0.784 |
| Gastric cancer | 1.44 | 0.34–6.08 | 0.612 |
| Hepatitis B | 3.10 | 1.25–7.68 | 0.014 |
| Low HDL cholesterolemia | 1.41 | 0.97–2.05 | 0.067 |
| Rhinitis | 1.78 | 1.26–2.51 | 0.001 |
| Chronic otitis media | 1.34 | 0.74–2.43 | 0.328 |
| Chronic sinusitis | 14.55 | 10.06–21.05 | <0.001 |
| HDL (<40 mg/dL) | 0.82 | 0.62–1.10 | 0.192 |
| GOT (>40 IU/L) | 1.82 | 0.86–3.81 | 0.113 |
| BUN (>24 mg/dL) | 1.90 | 0.92–3.93 | 0.080 |
| Lead (>10 µg/dL) | 1.07 | 0.38–3.04 | 0.888 |
| Mercury (>15 µg/dL) | 1.20 | 0.42–3.34 | 0.730 |
OR, odds ratio; CI, confidence interval; HDL, high density lipoprotein; GOT, glutamic oxaloacetic transaminase; BUN, blood urea nitrogen; each exposure variable is adjusted for all other variables in the table; After conversion of continuous variables to dichotomous variables (normal vs. abnormal) according to their normal laboratory range, blood and urine test results were included in the multivariate logistic model.